Strong Vivian E, Galanis Charles J, Riedl Christopher C, Longo Valerie A, Daghighian Farhad, Humm John L, Larson Steven M, Fong Yuman
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Ann Surg Innov Res. 2009 Feb 21;3:2. doi: 10.1186/1750-1164-3-2.
Positron emission tomography (PET) identifies cancer deposits by detecting sites of gamma emissions that are released from radioactively labeled molecules targeting tumor to formulate a PET image. Correlating preoperative PET scans with intraoperative findings remains a challenge. We investigated whether high-energy gamma emissions detected by a novel hand-held PET probe would detect tumors and offer a real-time method to localize tumor intraoperatively. Furthermore, we investigated the novel beta probe, which detects emissions at a shorter range than gamma emissions, making them undetectable by PET scanners, but potentially valuable for close range intraoperative detection of tumor deposits.
Six-to-eight-week-old athymic mice were injected with one of four possible tumor cell lines: gastric, pancreas, squamous cell and breast cancer. After tumors reached at least 1 cm in size, they were euthanized and imaged with a micro-PET imager. Hand-held gamma and beta probes were then used in vivo and ex vivo to measure high-energy gamma and beta emissions.
The portable PET probes detected high-energy gamma and beta emissions from all tumors evaluated. These emissions were reproducible and we established that beta emissions correlate with high-energy gamma emissions and conventional PET scans. There was a strong positive correlation (R = 0.8) between gamma and beta counts. Beta emission showed a stronger correlation than gamma emission with overall tissue radioactivity.
This study is the first to demonstrate that gamma emission detected by conventional PET imaging correlates with beta emissions. This study shows that compared to detection of gamma emissions, beta counts may offer superior real-time localization of tumor deposits. Intraoperative portable PET probe may become a useful way to exploit tumor biology and PET technology to guide real-time tissue characterization during surgery.
正电子发射断层扫描(PET)通过检测放射性标记分子靶向肿瘤释放的伽马射线发射部位来识别癌症沉积物,从而形成PET图像。将术前PET扫描结果与术中发现相关联仍然是一项挑战。我们研究了一种新型手持式PET探头检测到的高能伽马射线发射是否能检测到肿瘤,并提供一种术中实时定位肿瘤的方法。此外,我们还研究了新型贝塔探头,它检测的发射范围比伽马射线短,PET扫描仪无法检测到,但可能对术中近距离检测肿瘤沉积物有价值。
给6至8周龄的无胸腺小鼠注射四种可能的肿瘤细胞系之一:胃癌、胰腺癌、鳞状细胞癌和乳腺癌。肿瘤长到至少1厘米大小后,对小鼠实施安乐死并用微型PET成像仪进行成像。然后在体内和体外使用手持式伽马和贝塔探头测量高能伽马和贝塔射线发射。
便携式PET探头检测到了所有评估肿瘤的高能伽马和贝塔射线发射。这些发射是可重复的,并且我们确定贝塔射线发射与高能伽马射线发射以及传统PET扫描相关。伽马和贝塔计数之间存在很强的正相关(R = 0.8)。与总体组织放射性相比,贝塔射线发射显示出比伽马射线发射更强的相关性。
本研究首次证明传统PET成像检测到的伽马射线发射与贝塔射线发射相关。该研究表明,与检测伽马射线发射相比,贝塔计数可能在肿瘤沉积物的实时定位方面更具优势。术中便携式PET探头可能成为利用肿瘤生物学和PET技术在手术期间指导实时组织特征分析的有用方法。